TrialInternational journal of clinical oncology2023

Veliparib with frontline chemotherapy and as maintenance in Japanese women with ovarian cancer: a subanalysis of efficacy, safety, and antiemetic use in the phase 3 VELIA trial.

Mika Mizuno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.